Express Pharma
Browsing author
Salil sule
Novartis’ Gilenya reduces brain shrinkage matters for people with MS
Read more
Schizophrenia has group of eight genetically distinct disorders
Read more
Merck Serono to discontinue clinical development programme of tecemotide
Read more
Glenmark’s TRPA1 antagonist shows positive data
Read more
Bone Therapeutics receives clearance
Read more
Spill resistant formulations: No crying over spilt syrups!
Read more
Sanofi’s dengue vaccine candidate completes efficacy study
Read more
Novartis’ Ultibro Breezhaler reduces COPD flare ups
Read more
Novartis’ KAE609 shows promise as next generation treatment for malaria
Read more
Merck Serono initiates phase II study of AntiPDL1 antibody in mMCC
Read more
Posts navigation
Page 1 of 2
Page 2 of 2
Next